Subjective endpoints in clinical trials: the case for blinded independent central review

Overview of attention for article published in Open Access Journal of Clinical Trials, September 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer

Article in Journal of Cancer Research and Clinical Oncology (October 2022)

Value of Central Review of RECIST v1.1 Outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer

Preprint in Research Square (August 2022)

A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial

Article in American Heart Journal (December 2016)